We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sanofi Plans Clinical Trials Program to Assess Possible Cancer Risk of Insulin
Sanofi Plans Clinical Trials Program to Assess Possible Cancer Risk of Insulin
September 29, 2009
Sanofi-Aventis has proposed a research program to gather data on whether there is an association between cancer and the use of its Lantus diabetes drug.